InvestorsHub Logo
Followers 276
Posts 32657
Boards Moderated 0
Alias Born 11/14/2013

Re: FeMike post# 670134

Monday, 02/05/2024 12:03:41 PM

Monday, February 05, 2024 12:03:41 PM

Post# of 697078
What is the current SOC? Chemo radiation.
How did NWBO conduct the nGBM trial? With initial concurrent Temodar and DCVax-l.

The Company’s approved PIP includes 2 clinical trials: one for newly diagnosed pediatric high grade glioma (HGG), and one for recurrent pediatric HGG. In each of the 2 pediatric trials, 24 patients will be treated with DCVax-L on the same treatment schedule as in the Company’s Phase III trial in adult glioblastoma patients.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News